Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia

Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia

Abstract Background Hyperandrogenism and supraphysiologic glucocorticoid replacement may lead to subclinical atherosclerosis in people with congenital adrenal hyperplasia (CAH) and predispose the development of cardiovascular diseases from an early age. Objectives To determine if cardiometabolic ris...

Full description

Bibliographic Details
Main Authors:	Tania M. Espinosa Reyes, Alba Katherine Pesántez Velepucha, Julio Oscar Cabrera Rego, Wendy Valdés Gómez, Emma Domínguez Alonso, Henrik Falhammar
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	BMC Endocrine Disorders
Subjects:	21-hydroxylase deficiency Endothelial dysfunction Carotid intima media thickness 17-hydroxyprogesterone Blood pressure Insulin resistance
Online Access:	https://doi.org/10.1186/s12902-023-01499-9

Similar Items

Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden
by: Fredrik Sahlander, et al.
Published: (2022-12-01)

Irregular Menstruation-Hirsutism-Infertility: Clinical Management of Non-Classic Congenital Adrenal Hyperplasia
by: NIE Zhimei, et al.
Published: (2023-07-01)

Newborn screening for congenital adrenal hyperplasia in New York State
by: Melissa Pearce, et al.
Published: (2016-06-01)

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
by: O.V. Rykova
Published: (2019-08-01)

Variation in serum adrenal hormones in female 21-hydroxylase deficient patients
by: Ditte Sofie Dahl Sørensen, et al.
Published: (2022-06-01)

A Male Subject with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Which Was Diagnosed at 31 Years Old due to Infertility
by: Hideaki Kaneto, et al.
Published: (2023-01-01)

Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
by: Swetha Rangaswamaiah, et al.
Published: (2020-07-01)

Precocious puberty due to congenital adrenal hyperplasia. Case report
by: María Fernanda Dallos-Lara, et al.
Published: (2020-01-01)

Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review
by: Elisabeth Daae, et al.
Published: (2020-03-01)

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia
by: Elham Hashemi Dehkordi, et al.
Published: (2021-01-01)

Congenital adrenal hyperplasia
by: Miolski Jelena, et al.
Published: (2021-01-01)

Congenital adrenal hyperplasia at the Lagos University Teaching Hospital: A 10-year review
by: Elizabeth Eberechi Oyenusi, et al.
Published: (2016-01-01)

THE DNA-DIAGNOSTICS FORM CONGENITAL ADRENAL HYPERPLASIA CHILDREN
by: V. V. Grigoryan, et al.
Published: (2017-07-01)

Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
by: Preet K. Matharu, et al.
Published: (2022-10-01)

Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
by: Tomoyo Itonaga, et al.
Published: (2023-02-01)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020-08-01)

Analysis of a pitfall in congenital adrenal hyperplasia newborn screening: evidence of maternal use of corticoids detected on dried blood spot
by: Muriel Houang, et al.
Published: (2022-06-01)

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
by: Georgios Papadakis, et al.
Published: (2019-06-01)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Myrthe J. M. Verhees, et al.
Published: (2021-03-01)

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
by: Rita Santos Silva, et al.
Published: (2022-03-01)

Congenital adrenal hyperplasia with maple syrup urine disease: an example of consanguinity impact
by: Zuhair Rahbeeni, et al.
Published: (2019-12-01)

Hiperplasia adrenal congênita: dosagem da 17-hidroxiprogesterona basal para seleção e casos para realização do teste de estímulo com ACTH sintético Congenital adrenal hyperplasia: measurement of basal 17-hydroxyprogesterone as a screening test to select patients for the synthetic ACTH provocative test
by: Lúcia Helena Coelho Nóbrega, et al.
Published: (2004-05-01)

IS CONGENITAL ADRENAL HYPERPLASIA DUE TO 21- HYDROXYLASE DEFICIENCY DECEPTIVE DISEASE? MANAGEMENT AND DIFFERENTIATION OF SYNDROME IN ADULTS
by: Anna Nowak
Published: (2017-12-01)

Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
by: Bas P. H. Adriaansen, et al.
Published: (2022-12-01)

Characteristics of Congenital Adrenal Hyperplasia Diagnosed in Adulthood: A Literature Review and Case Series
by: Joanna Hubska, et al.
Published: (2023-01-01)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
by: Helmuth G. Dörr, et al.
Published: (2018-06-01)

Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care
by: Jin-Ho Choi, et al.
Published: (2017-02-01)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Larissa G. Gomes, et al.
Published: (2013-01-01)

Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Jin-Ho Choi, et al.
Published: (2016-03-01)

Do Non-Functional Adrenal Adenomas Affect Metabolic Profile and Carotid Intima-Media Thickness? A Single Centre Study from Poland
by: Magdalena Szychlińska, et al.
Published: (2023-07-01)

Congenital adrenal hyperplasia - experience from a tertiary centre in South India
by: George Belinda, et al.
Published: (2012-01-01)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
by: Tomoyo Itonaga, et al.
Published: (2022-01-01)

Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
by: Kotb Abbass Metwalley, et al.
Published: (2019-03-01)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
by: Antonio Balsamo, et al.
Published: (2020-12-01)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
by: Atsumi Tsuji-Hosokawa, et al.
Published: (2021-06-01)

ANALYSIS CYP21A2 GENE MUTATIONS TECHNIQUE IN PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA
by: Chernushyn S. Yu., et al.
Published: (2014-02-01)

Does carotid intima-media thickness have relationship with polycystic ovary syndrome?
by: Zahra Allameh, et al.
Published: (2013-01-01)

Clinical Characteristics of Taiwanese Children With Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency in the Pre-screening Era
by: Cheng-Ting Lee, et al.
Published: (2010-02-01)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
by: Helmuth G. Dörr, et al.
Published: (2019-03-01)

Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
by: Mouna Feki Mnif, et al.
Published: (2013-01-01)